Abstract | OBJECTIVE: To examine the microbiologic and clinical efficacy of a 5-day course of cefdinir in the treatment of tympanocentesis-documented acute otitis media (AOM). DESIGN: Open label noncomparative trial. SETTING: Primary care, ambulatory. PATIENTS: Children ages 6 months through 12 years with signs of AOM and middle ear effusion confirmed by tympanometry in at least one ear. INTERVENTION: Patients underwent tympanocentesis at baseline and received cefdinir 7 mg/kg twice a day for 5 days. MAIN OUTCOME MEASURES: Presumptive eradication of middle ear pathogens determined by clinical cure of signs and symptoms of AOM at end of therapy (Study Days 7 to 9) and Visit 3 (Study Days 16 to 21). RESULTS: A total of 125 of 177 enrolled children had 134 pathogens isolated by tympanocentesis: Streptococcus pneumoniae, 69 (51.5%); Haemophilus influenzae 44 (32.8%; beta-lactamase-positive in 18 of 44 strains); beta-lactamase-positive Moraxella catarrhalis, 15 (11.2%); and Streptococcus pyogenes, 6 (4.5%). The clinical cure rates by patient in the microbiologically and overall clinically evaluable groups, respectively, were 73% (84 of 115) and 77.4% (130 of 168) at the end of therapy visit and 57.4% (66 of 115) and 61.9% (104 of 168) at Visit 3. Presumptive eradication rates at end of therapy were 8 of 11 (72.7%) and 4 of 8 (50%) for patients with penicillin-intermediate and -resistant S. pneumoniae isolates, respectively. Adverse reactions occurred in 16% of patients, with diarrhea (11%) occurring most frequently. CONCLUSIONS: A 5-day regimen of cefdinir was effective in the eradication of the common causative pathogens of nonrefractory AOM, including intermediate penicillin-resistant S. pneumoniae and beta-lactamase-producing organisms. Cefdinir should be considered a suitable second line antibiotic for AOM.
|
Authors | S L Block, J A Hedrick, J Kratzer, M A Nemeth, K J Tack |
Journal | The Pediatric infectious disease journal
(Pediatr Infect Dis J)
Vol. 19
Issue 12 Suppl
Pg. S153-8
(Dec 2000)
ISSN: 0891-3668 [Print] United States |
PMID | 11144397
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Acoustic Impedance Tests
- Acute Disease
- Bacterial Infections
(drug therapy, microbiology)
- Cefdinir
- Cephalosporins
(pharmacology, therapeutic use)
- Child
- Child, Preschool
- Female
- Haemophilus influenzae
(drug effects, isolation & purification)
- Humans
- Infant
- Male
- Microbial Sensitivity Tests
- Moraxella catarrhalis
(drug effects, isolation & purification)
- Otitis Media
(diagnosis, drug therapy, microbiology)
- Otitis Media with Effusion
(diagnosis, drug therapy)
- Penicillin Resistance
- Streptococcus pneumoniae
(drug effects, isolation & purification)
- Streptococcus pyogenes
(drug effects, isolation & purification)
- Treatment Outcome
|